Project title: OLIGOFASTX: Integrated platform for the sustainable development of oligonucleotide-based therapeutics
Coordinating Company: Sylentis S.A.
Participating partner companies:
- Sylentis S.A.
- Aptatargets S.L.
- Aptus Biotech S.L.
- Arthex Biotech S.L.
- Biotechnology Development for Indutry in Pharmaceuticals S.L.
- Nanovex Biotechnologies S.L.
- Nostrum Biodiscovery S.L
Project budget: 7.402.487,00 €.
Financing: This project has received 73.18% of co-financing in the Science and Innovation Research Missions action included in the State Sub-programme for Public-Private Collaboration managed by the Centre for the Development of Industrial Technology, in its capacity as a financing agent of Law 14/2011, of 1 June, on Science, Technology and Innovation.
Likewise, the call for Science and Innovation Missions 2022 is included among the actions foreseen in the National Recovery, Transformation and Resilience Planwhich outlines the roadmap for the modernisation of the Spanish economy, the recovery of economic growth and job creation, for strong, inclusive and resilient economic reconstruction after the COVID crises, and for responding to the challenges of the next decade.
This action is aimed at pre-competitive research projects, led by companies that pursue relevant research that proposes solutions to cross-cutting and strategic challenges of Spanish society, improves the knowledge and technology base on which Spanish companies rely to compete, while stimulating public-private cooperation.